争夺霸权：病毒与细胞之间的核酸相互作用
Battle for supremacy: nucleic acid interactions between viruses and cells.
作者信息
Hennessy Elizabeth J, FitzGerald Garret A
出版信息
J Clin Invest. 2021 Feb 1;131(3). doi: 10.1172/JCI144227.
Abstract
Since the COVID-19 pandemic swept across the globe, researchers have been trying to understand its origin, life cycle, and pathogenesis. There is a striking variability in the phenotypic response to infection with SARS-CoV-2 that may reflect differences in host genetics and/or immune response. It is known that the human epigenome is influenced by ethnicity, age, lifestyle, and environmental factors, including previous viral infections. This Review examines the influence of viruses on the host epigenome. We describe general lessons and methodologies that can be used to understand how the virus evades the host immune response. We consider how variation in the epigenome may contribute to heterogeneity in the response to SARS-CoV-2 and may identify a precision medicine approach to treatment.
摘要
自新冠疫情席卷全球以来，研究人员一直在努力了解其起源、生命周期和发病机制。感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）后的表型反应存在显著差异，这可能反映了宿主基因和/或免疫反应的不同。众所周知，人类表观基因组受种族、年龄、生活方式和环境因素影响，包括既往病毒感染。本综述探讨病毒对宿主表观基因组的影响。我们描述了可用于理解病毒如何逃避宿主免疫反应的一般经验和方法。我们考虑表观基因组的变异如何导致对SARS-CoV-2反应的异质性，并可能确定一种精准医学治疗方法。
相似文献
1
Battle for supremacy: nucleic acid interactions between viruses and cells.争夺霸权：病毒与细胞之间的核酸相互作用
J Clin Invest. 2021 Feb 1;131(3). doi: 10.1172/JCI144227.
2
Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV.拓扑分析用于序列变异：以 54 个国家 2000 多个 COVID-19 感染 SARS-CoV-2 序列为例，与 SARS-CoV-1 和 MERS-CoV 进行比较。
Infect Genet Evol. 2021 Mar;88:104708. doi: 10.1016/j.meegid.2021.104708. Epub 2021 Jan 6.
3
Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.从 COVID-19 患者的鼻咽样本中进行转录组分析，并与其他 SARS-CoV-2 感染模型进行比较分析，揭示了宿主针对 SARS-CoV-2 的不同反应。
J Transl Med. 2021 Jan 7;19(1):32. doi: 10.1186/s12967-020-02695-0.
4
Modulation of host epigenome by coronavirus infections and developing treatment modalities for COVID-19 beyond genetics.冠状病毒感染对宿主表观基因组的调控及 COVID-19 超越遗传学的治疗模式。
Eur Rev Med Pharmacol Sci. 2021 Oct;25(19):5947-5964. doi: 10.26355/eurrev_202110_26872.
5
Genetic variation analyses indicate conserved SARS-CoV-2-host interaction and varied genetic adaptation in immune response factors in modern human evolution.遗传变异分析表明，在现代人类进化过程中，SARS-CoV-2 与宿主的相互作用是保守的，而在免疫反应因子方面则存在着不同的遗传适应性。
Dev Growth Differ. 2021 Apr;63(3):219-227. doi: 10.1111/dgd.12717. Epub 2021 Mar 21.
6
Clocks, Viruses, and Immunity: Lessons for the COVID-19 Pandemic.时钟、病毒与免疫：新冠疫情的启示
J Biol Rhythms. 2021 Feb;36(1):23-34. doi: 10.1177/0748730420987669. Epub 2021 Jan 22.
7
The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.microRNAs 在调节人类细胞中 SARS-CoV-2 感染中的作用：系统评价。
Infect Genet Evol. 2021 Jul;91:104832. doi: 10.1016/j.meegid.2021.104832. Epub 2021 Apr 1.
8
SARS-CoV-2 infection and the antiviral innate immune response.严重急性呼吸综合征冠状病毒2型感染与抗病毒固有免疫反应
J Mol Cell Biol. 2020 Nov 26;12(12):963-967. doi: 10.1093/jmcb/mjaa071.
9
The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense.SARS-CoV-2 的突变特征主要由宿主抗病毒防御决定。
Viruses. 2021 Mar 2;13(3):394. doi: 10.3390/v13030394.
10
SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity.SARS-CoV-2 进入相关的病毒和宿主遗传变异：对 COVID-19 严重程度、免疫逃避和传染性的影响。
Int J Mol Sci. 2021 Mar 17;22(6):3060. doi: 10.3390/ijms22063060.
引用本文的文献
1
MIAOME: Human microbiome affect the host epigenome.妙妙：人类微生物组会影响宿主表观基因组。
Comput Struct Biotechnol J. 2022 May 17;20:2455-2463. doi: 10.1016/j.csbj.2022.05.024. eCollection 2022.
本文引用的文献
1
analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs.分析 SARS-CoV-2 基因组：来自 SARS 编码非编码 RNA 的启示。
Front Cell Infect Microbiol. 2022 Nov 28;12:966870. doi: 10.3389/fcimb.2022.966870. eCollection 2022.
2
The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2.SARS-CoV-2 的短程和长程 RNA-RNA 互作组。
Mol Cell. 2020 Dec 17;80(6):1067-1077.e5. doi: 10.1016/j.molcel.2020.11.004. Epub 2020 Nov 5.
3
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.COVID-19 危重症患者体内针对 I 型干扰素的自身抗体。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
4
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.COVID-19 危重症患者的 I 型 IFN 免疫先天缺陷。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
5
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.美国 31461 例 COVID-19 成年人死亡相关合并症：一项联合电子病历分析。
PLoS Med. 2020 Sep 10;17(9):e1003321. doi: 10.1371/journal.pmed.1003321. eCollection 2020 Sep.
6
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting.冠状病毒RNA校对：分子基础与治疗靶点
Mol Cell. 2020 Sep 3;79(5):710-727. doi: 10.1016/j.molcel.2020.07.027. Epub 2020 Aug 4.
7
Epigenetic silencing of CD4 expression in nonpathogenic SIV infection in African green monkeys.非致病性 SIV 感染非洲绿猴时 CD4 表达的表观遗传沉默。
JCI Insight. 2020 Sep 17;5(18):139043. doi: 10.1172/jci.insight.139043.
8
The Role of the Liver-Specific microRNA, miRNA-122 in the HCV Replication Cycle.肝脏特异性 microRNA（miRNA-122）在 HCV 复制周期中的作用。
Int J Mol Sci. 2020 Aug 7;21(16):5677. doi: 10.3390/ijms21165677.
9
Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations.人群中 SARS-CoV-2 宿主细胞进入因子表达的遗传变异性。
Genes Immun. 2020 Aug;21(4):269-272. doi: 10.1038/s41435-020-0107-7. Epub 2020 Aug 6.
10
T cell responses in patients with COVID-19.新冠病毒肺炎患者的T细胞反应
Nat Rev Immunol. 2020 Sep;20(9):529-536. doi: 10.1038/s41577-020-0402-6. Epub 2020 Jul 29.
Zotero 插件